Shares of Balchem BCPC remained unaffected after the company reported Q1 results.
Quarterly Results
Earnings per share increased 7.41% over the past year to $0.87, which beat the estimate of $0.84.
Revenue of $185,656,000 rose by 6.43% year over year, which beat the estimate of $181,590,000.
Outlook
Earnings guidance hasn't been issued by the company for now.
Revenue guidance hasn't been issued by the company for now.
How To Listen To The Conference Call
Date: Apr 30, 2021
Time: 11:00 AM
ET Webcast URL: https://balchem.com/resources/balchem-to-present-balchem-1st-quarter-2021-financial-results/
Technicals
Company's 52-week high was at $132.50
52-week low: $79.75
Price action over last quarter: Up 2.51%
Company Description
Balchem manufactures ingredients, nutrients, and chemicals for a wide variety of industries, including human nutrition, animal nutrition, and oil and gas. The company offers a wide variety of product lines, with some highly customized and others commodity-oriented. After the 2014 acquisition of SensoryEffects, the human nutrition and health segment now generates the largest share of companywide revenue and profits.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.